michael marco id epi class slides on hpv natural history

43
Epidemiology & Natural History of HPV Infection and its Causal Relationship with Invasive Cervical Cancer Michael Marco, M.Phil., MPH, ID/Epi Pre-doctoral Training Fellow, CIDER, ICAP Infectious Disease Epidemiology - P8406 15 April 2010

Upload: mikemarco

Post on 29-Jun-2015

1.372 views

Category:

Health & Medicine


1 download

TRANSCRIPT

Page 1: Michael Marco ID Epi class slides on HPV Natural History

Epidemiology & Natural History of HPV Infection and its Causal Relationship with

Invasive Cervical Cancer

Michael Marco, M.Phil., MPH, ID/Epi Pre-doctoral Training Fellow, CIDER, ICAP

Infectious Disease Epidemiology - P840615 April 2010

Page 2: Michael Marco ID Epi class slides on HPV Natural History

Outline

HPV prevalence in women & men Risk factors for acquiring HPV Age & HPV Limitations of HPV serologic testing & current

understanding of immunity HPV detection HPV persistence, clearance & reactivation High-risk HPV & invasive cervical cancer (ICC)

Prevalence of disease & type-specific HPV

ICC natural history: SIL & CIN ICC screening: PAP vs. HPV (measurement error)

Page 3: Michael Marco ID Epi class slides on HPV Natural History

• A DNA Virus

• Preferentially infects squamous epithelial cells

Human Papillomavirus (HPV)

Page 4: Michael Marco ID Epi class slides on HPV Natural History

CDC 2008Median Age of Sexual Debut for Girls is 17.6 years

Page 5: Michael Marco ID Epi class slides on HPV Natural History

Winer, et al. 2003

Page 6: Michael Marco ID Epi class slides on HPV Natural History

CDC 2008

(Debatable; more for progression to cancer)

Non-penetrative transmission has been documented, but is less likely

(e.g., HIV) HPV in HIV+ women (pre-and post-HAART) is worthy a separate lecture. See Steben & Franco-Duarte review

Page 7: Michael Marco ID Epi class slides on HPV Natural History
Page 8: Michael Marco ID Epi class slides on HPV Natural History
Page 9: Michael Marco ID Epi class slides on HPV Natural History

HPV Prevalence in Women Varies Markedly in-and-between Populations

Possiblyan artifact of different assays (“home brewed”) used to measure HPV?

Page 10: Michael Marco ID Epi class slides on HPV Natural History
Page 11: Michael Marco ID Epi class slides on HPV Natural History

Methodological Issues to Consider with HPV Prevalence in Men

Page 12: Michael Marco ID Epi class slides on HPV Natural History

in

Page 13: Michael Marco ID Epi class slides on HPV Natural History

CDC 2008

HPV Prevalence is Similar Among U.S. Racial/Ethnic Groups

Page 14: Michael Marco ID Epi class slides on HPV Natural History

HPV Prevalence by Age

CDC 2008

Page 15: Michael Marco ID Epi class slides on HPV Natural History

Why Does HPV Prevalence in Women Differ by Age & their Country of Origin?

Page 16: Michael Marco ID Epi class slides on HPV Natural History

High Risk HPV Prevalence Differ by Age in Women, but not Men

Page 17: Michael Marco ID Epi class slides on HPV Natural History

CDC 2008

Page 18: Michael Marco ID Epi class slides on HPV Natural History
Page 19: Michael Marco ID Epi class slides on HPV Natural History

HPV Detection With an HPV DNA test

(Hybrid Capture II (The only FDA-approved HPV Test) Can analyze residual fluid of a liquid-based

cytology specimen from a Pap smear Detects only “high risk” (hr)HPV types, but does

not identify the individual type. Only research assays (“home brewed”) offer information on the specific genotype Would be useful for determining vaccine effectiveness in

the community? Indications for use

Routine adjunct to Pap in women 30 and overManagement of ASCUS (atypical squamous cells of

undetermined significance)

Page 20: Michael Marco ID Epi class slides on HPV Natural History

Collection of HPV for DNA Amplification

X

Page 21: Michael Marco ID Epi class slides on HPV Natural History

Hybrid Capture II

Page 22: Michael Marco ID Epi class slides on HPV Natural History

What Dose HPV Persistence, Clearance & Reactivation Mean???

Page 23: Michael Marco ID Epi class slides on HPV Natural History

Persistence of hrHPV Type is a Strong Risk Factor for Precancerous Lesions

Ho, et al. NEJM 1998

Page 24: Michael Marco ID Epi class slides on HPV Natural History
Page 25: Michael Marco ID Epi class slides on HPV Natural History

Why Should We Care About HPV Infection?

Page 26: Michael Marco ID Epi class slides on HPV Natural History

From 1000 Cases of Cervical Cancer, HPV DNA was Found in 99.7%

Page 27: Michael Marco ID Epi class slides on HPV Natural History

CDC 2008

Page 28: Michael Marco ID Epi class slides on HPV Natural History

Cervical Cancer is the 3rd Leading Cancer in Women

WHO IARC, 2006

Page 29: Michael Marco ID Epi class slides on HPV Natural History
Page 30: Michael Marco ID Epi class slides on HPV Natural History
Page 31: Michael Marco ID Epi class slides on HPV Natural History

Natural History of HPV Infection and Cervical Cancer

Page 32: Michael Marco ID Epi class slides on HPV Natural History

Natural History of HPV Infection and Cervical Cancer

Page 33: Michael Marco ID Epi class slides on HPV Natural History

SIL: cytological (cells from Pap smear) CIN: histological (tissue from colposcopy)

Page 34: Michael Marco ID Epi class slides on HPV Natural History
Page 35: Michael Marco ID Epi class slides on HPV Natural History
Page 36: Michael Marco ID Epi class slides on HPV Natural History

Colposcopy +/- Biopsy are Warranted after an Abnormal Pap or Repeat hrHPV Detection

Page 37: Michael Marco ID Epi class slides on HPV Natural History

Measurement Error is Common in the Reading of Colposcopic Biopsies

Shiffman, et al. 2007

Page 38: Michael Marco ID Epi class slides on HPV Natural History

CIN can Clear Spontaneously or Regress

CIN 1 lesions spontaneously clear in 60% of the cases and rarely progresses to cancer (1%)

CIN 2 & CIN 3 lesions spontaneously clear in 30-40% of cases, however a higher percentage progress to cancer >12% if untreated

Cannot tell by the “look” of the lesions which ones will progress

CIN 2 is defined as an “intermediate diagnosis,” but is treated for safety as if it was CIN 3

Development of CIN 2 or CIN 3 are most often used as “surrogate endpoints” for invasive cervical cancer in prospective cohort studies

An immediate vs. differed treatment study for CIN 2 lesions would be beneficial, however, no IRB would approve it.

Moskowitz 2007; Woodman 2007, Wacholder 2003

Page 39: Michael Marco ID Epi class slides on HPV Natural History
Page 40: Michael Marco ID Epi class slides on HPV Natural History

Our study found that a single round of HPV testing was associated with a significant decline in the rate of advanced cervical cancers and associated deaths, as compared with the unscreened control group. By contrast, there was no significant reduction in the rate of death in either the cytologic-testing group or the VIA group, as compared with the control group. NOTE: no cancer-related deaths were observed in any of the HPV-negative women.

Page 41: Michael Marco ID Epi class slides on HPV Natural History

Shiffman & Wacholder 2009

Page 42: Michael Marco ID Epi class slides on HPV Natural History

With HPV Testing, is it Now Time to Retire the Pap?

Page 43: Michael Marco ID Epi class slides on HPV Natural History

What about HPV & the Need for Vaccination in Animals?

Dad, I am nearing my sexual debut. Can I be the first puppy to get the HPV vaccine?